|
2025
|
G/S
|
pharmaceutical preparations in the nature of immunotherapies for the treatment of cancer; vaccines |
|
2024
|
Invention
|
Neoantigen immunotherapy. e.g.,e.g.,e.g., a tumor-infiltrating lymphocyte (TIL) therapy). The dis... |
|
|
Invention
|
Compositions and methods for treating cancer. The disclosure is directed to methods for treating ... |
|
|
Invention
|
Compositions and methods for modulating sialic acid production and treating hereditary inclusion ... |
|
2023
|
Invention
|
Methods for the treatment of lung tumors.
The present disclosure provides composition formulated... |
|
2022
|
Invention
|
Methods for treatment response to cancers. Disclosed herein are methods for predicting the respon... |
|
|
Invention
|
Methods for the treatment of viral respiratory infections.
Compositions and methods for treatmen... |
|
|
Invention
|
Methods for treating cancers.
Disclosed herein are methods for predicting the responsiveness of ... |
|
|
Invention
|
Methods for treating cancers. Disclosed herein are methods for predicting the responsiveness of a... |
|
2021
|
Invention
|
Composition formulated into inhalable dosage forms for the treatment of lung|tumors. The present ... |
|
|
Invention
|
Methods for the treatment of viral respiratory infections. Compositions and methods for treatment... |
|
|
Invention
|
Methods for treating cancers. Compositions and methods for prevention of ovarian cancer recurrenc... |
|
|
Invention
|
Methods for treating cancers using gm-csf encoding polynucleotide and additional agents. Composit... |
|
2017
|
Invention
|
Furin-knockdown and gm-csf-augmented (fang) cancer vaccine. Compositions and methods for cancer t... |
|
2016
|
Invention
|
Individualized cancer therapy.
In certain embodiments, the invention provides methods for treati... |
|
|
Invention
|
Individualized cancer therapy. In certain preferred embodiments, the invention provides methods f... |
|
2015
|
Invention
|
Furin-knockdown bi-functional rna. Compositions and methods to attenuate the immunosuppressive ac... |
|
|
Invention
|
Multiple targeted rnai for the treatment of cancers. The present invention includes compositions ... |
|
|
Invention
|
Processes for the preparation of highly pure plasmid compositions.
The present disclosure genera... |
|
2014
|
Invention
|
Individualized cancer therapy. In certain embodiments, the invention provides methods for treatin... |
|
|
Invention
|
Shrna molecules and methods of use thereof. The present invention relates to certain novel shRNA ... |
|
|
Invention
|
Construction of bifunctional short hairpin rna. A method for designing a bi-shRNA expression cass... |
|
2013
|
Invention
|
Polypeptides having colanic acid-degrading activity. The present disclosure generally relates to ... |
|
|
Invention
|
Kras mutations. The present invention includes compositions and methods for making and using a bi... |
|
|
Invention
|
Bi-functional short-hairpin rna (bi-shrna) specific for single-nucleotide kras mutations. The pre... |
|
|
Invention
|
Ewing's sarcoma bifunctional shrna design. The present invention includes compositions and method... |
|
|
Invention
|
Methods and compositions to treat cancer using bifunctional src-3 shrna. The present invention in... |
|
|
Invention
|
Antagonists of mir-196a. A miR-196a antagonist capable of inhibiting a miR-196a activity, the miR... |
|
2012
|
Invention
|
Therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroe... |
|
|
Invention
|
Targeted delivery using tissue-specific peptidomimetic ligands. Compositions and methods for tiss... |
|
|
Invention
|
Furin-knockdown and gm-csf-augmented (fang) cancer vaccine.
Compositions and methods for cancer ... |
|
|
Invention
|
Compositions and methods for treating prostate cancer. Compositions and methods to interfere with... |
|
|
Invention
|
Dipeptide mimics, libraries combining two dipeptide mimics with a third group, and methods for pr... |
|
|
Invention
|
Bi-functional shrna targeting stathmin 1 and uses thereof. The present invention includes bifunct... |
|
2011
|
G/S
|
Vaccines |
|
2010
|
Invention
|
Furin-knockdown bi-functional rna. The present invention includes compositions and methods to att... |
|
|
Invention
|
Furin-knockdown and gm-csf-augmented (fang) cancer vaccine. The present invention includes compos... |
|
|
Invention
|
Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing ... |
|
2009
|
Invention
|
Processes for the digestion of colanic acid. The present disclosure generally relates to processe... |
|
2006
|
G/S
|
Evaluation services, namely, providing medical research relating to novel cancer pharmaceuticals;... |
